Cardiac SurgeryRobbins P, Von Kier S, Forrest M, Royston D. "Activated Clotting Times are Shortened by Tranexamic Acid." Anesthesiology. Sept. 1998, V89, No 3A, A962. Von Kier S, Royston D. "Reduced Hemostatic Factor Transfusion using Heparinase-Modified [Thrombelastograph® Analysis] (TEG[®]) During Cardiopulmonary Bypass (CPB)." Anesthesiology. Sept. 1998, V89, No. 3A, A911. Shore-Lesserson L, Manspeizer HE, Francis S, DePerio M. "[Thrombelastograph® Analysis] Decreases Transfusion Requirements after Cardiac Surgery." Anesthesiology. Sept. 1998, V89, No3A, A246. Stammers AH, Bruda NL, Gonano C, Hartmann T. "Point-of-care coagulation monitoring: applications of the [Thrombelastograph® Analyzer]." Anesthesia. 1998,53 (Suppl 2), pp 1-80. Spiess BD. "Perioperative Coagulation Monitoring." Perioperative Transfusion Medicine. 1998. Kettner SC, Kozek SA, Groetzner JP, Gonano C, Schellongowski A, Kucera M, ZimpferM. "Effects of hypothermia on [Thrombelastograph® analysis] in patients undergoing cardiopulmonary bypass." British Journal of Anaesthesia. 1998;80:313-317. Ereth MH, Nuttall GA, Santrach PJ, Klindworth JT, Oliver WC, Schaff HV. "The Relation between the Platelet-activated Clotting Test (HemoSTATUS) and Blood Loss after Cardiopulmonary Bypass." Anesthesiology. 1998;88:962-9. Shore-Lesserson L, Manspeizer HE, Francis S, DePerio M. "Intraoperative [Thrombelastograph® Analysis] (TEG[®]) Reduces Transfusion Requirements." Anesth Analg. 1998;86;SCA101. Shore-Lesserson L, Manspeizer HE, Francis S, DePerio M. "Heparinase-Modified [Thrombelastograph® Analysis] During Bypass Predicts Mediastinal Tube Drainage." Anesth Analg. 1998;86;S104. Takeda T, Kohro S, Yamakage M, et al. "Effect of Recycled Autologous Blood Transfusion on in Vitro Blood Coagulability and Fibrinolysis." Anesth Analg. 1998:86;S110. Shulman G, McQuitty C, Vertrees RA, Conti VR. "Acute Normovolemic Red Cell Exchange for Cardiopulmonary Bypass in Sickle Cell Disease." Ann Thorac Surg. 1998;65. Ficek SJ, Stammers A, Ubeydullah D, et al. "Hemostatic Assessment of Patients Undergoing Intraaortic Balloon Pump Therapy." Journal of Extra-Corporeal Technology. June 1997. V29, No 2. McCarthy RJ, Tuman KJ, El-Ganzouri N, Ivankovich AD. "Influence of Heparin Reversal Methods on Whole Blood [Thrombelastograph®] Measures of Coagulation." Anesth Analg. 1997;84;S104. O'Connor CJ, Tuman KJ, McCarthy RJ, McCarthy WE, Ivankovich AD. "Multivariate Predictors of Bleeding and Transfusion in Reoperative CABG Surgery." Anesth Analg. 1997;84;S114. Wolman RL, Bardwell PS, Embrey J, Bowman T, Michael J, O'Rourke P, Roberts J, Weiss J, Shapiro J. "Empirical Versus [TEG®]-Guided Transfusion Practices During Cardiac Surgery." Anesth Analg. 1997;84;S223. Tomiyama Y, Yasumoto S, Sakata S, Kitahata H, Kimura H, Oshita S. "Coagulation Status of the Whole Blood Preoperatively Obtained in the Operating Room and Preserved at Room Temperature [Thrombelastograph®] Evaluation." Anesthesiology. September 1996. V85. No. 3A. Spiess BD. "Coagulation Monitoring in the perioperative period." Acta Anaestheisologica Scandinavica. 1996;109;V40:M29. Soltow LO, Spiess BD, Wahr J, Herskowitz A, et al. "Does Acadesine Contribute to Hypocoagulability after CABG Surgery." Anesth Analg. 1996;82,SCA97. Zimmermann J, McIntosh C, Clementi W, et al. "Heparin Reversal with NeutralaseTM (HEPARINASE I) in Adult Male Volunteers. Anesth Analg. 1996;82,SCA93. Robbins P, Forrest M, von Kier S, Royston D. "Can the [Thrombelastograph® Analyzer] (TEG[®]) Predict Dose Requirement for Aprotinin Therapy?" Anesthesiology. Sept. 1996. V85, No. 3A. Spiess BD. "[Thrombelastograph® Analysis] and Cardiopulmonary Bypass." Seminars in Thrombosis and Hemostasis. 1995. V21 Supplement 4. Shore-Lesserson L, Reich DL, DePerio M, Silvay G. "Autologous Platelet-Rich Plasmapheresis: Risk Versus Benefit in Repeat Cardiac Operations." Anesth Analg. 1998;81:229-35. Spiess BD, Gilles B, Chandler W, Verrier E. "Changes in Transfusion Therapy and Reexploration Rate After Institution of a Blood Management Program in Cardiac Surgical Patients." Journal of Cardiothoracic and Vascular Anesthesia. April 1995: V9, No.2. pp168-173. Thwaites BK, Mongan PD, Brown RS. [Thrombelastograph®] Evidence of Fibrinolysis Strongly Predicts Excess Bleeding After Cardiopulmonary Bypass." Anesthesia & Analgesia. April 1995;V80, No. 4S. Etzioni DA, Tobias MD, Jobes DR. "[Thrombelastograph® Analysis] Results are Easily Affected by Sample and Technique." Anesthesia & Analgesia. April 1995. V80, No. 4S. Copeland JG, Tsau PH, Arabia FA, Xie T. "Correlation of Clinical Embolic Events with Coagulability in a Patient with a Total Artificial Heart." Journal of Heart and Lung Transplantation. 1995; V14, No. 5. McCarthy RJ, Tuman KJ, Holm WE, Ivankovich AD. "Effects of Aspirin on Homologous Blood Requirements after Repeat Cardiac Operations." Anesthesia & Analgesia. Feb. 1995; V80, No. 2S. McCarthy RJ, Tuman KJ, Bednar LA, Holm WE, Ivankovich AD. "Effects of Heparinase and Protamine on Whole Blood Coagulation in the Presence and Absence of Heparin." Anesthesiology. September 1994;81(3A). Spiess BD, Soltow LO. "[Thrombelastograph® Analysis] is Best Preserved in High Dose Aprotinin Treated Repeat CABG Patients." Anesthesiology. September 1994;81(3A). Spiess BD, Soltow L, Dobbyn R, Chandler WL. "The Effects of Cardiopulmonary Bypass on Shear Moduleus in a Clinical Series of Cardiopulmonary Bypass Patients as Measured by [Thrombelastograph® Analysis] ." Anesthesiology. September 1994;81(3A). MaGuire DP, McNulty SE. "Heparin Bonded Pulmonary Artery Catheters May Affect the Thromboelastogram and Activated Coagulation Time." Anesthesiology. September 1994;81(3A). Spiess BD, Soltow L, Dobbyn R. "[Thrombelastograph® Analysis] Preoperatively can Predict Postoperative Risk of Severe Hemorrhage in Valve Surgery: A Report of a Clinical Series." Anesthesiology. September 1994; 81(3A). Tuman KJ, McCarthy R, Djuric M, Rizzo BA, Ivankovich A. "Evaluation of Coagulation During Cardiopulmonary Bypass with a Heparinase-Modified [Thrombelastograph®] Assay." Journal of Cardiothoracic and Vascular Anesthesia. (April), 1994:V8, No.2, pp144-149. McCarthy R, Tuman K, Ivankovich AD. "Heparinase Enhanced Whole Blood [Thrombelastograph® Analysis] During Cardiopulmonary Bypass is Predictive of Coagulation Status after Protamine Reversal of Heparin." Anesthesiology. Sept. 1993, V79, No. 3A. McCarthy R, Tuman K, Djurie M, Rizzo V, Ivankovich AD. "Effect of Heparinase on Viscoelastic Coagulation Measurements in the Presence and Absence of Heparin." Anesthesiology. Sept. 1993, V79, No. 3A. Wall MH, Spiess BD, Gillies B, Chandler WL. "[Thrombelastograph® Analysis] With Added Heparinase or Protamine Sulfate During Cardiopulmonary Bypass." Anesthesiology. Sept. 1993, V79, No.3A. Essels JH, Martin TJ, Salinas J, Thompson JM, Smith VC. "Comparison of [Thrombelastograph® Analysis] to Bleeding Time and Standard Coagulation Tests in Patients After Cardiopulmonary Bypass." Journal of Cardiothoracic and Vascular Anesthesia. August 1993, V7, No. 4, pp410-415. Dorman BH, Spinale FG, Bailey MK, Kratz JM, Roy RC. "Identification of patients at risk for excessive blood loss during coronary artery bypass surgery: [Thrombelastograph® analysis] versus coagulation screen." Anesth Analg April 1993; V76;694-700. McCarthy R, Tuman K, Djuric M, Rizzo V, Ivankovich AD. "Use of Heparinase to Evaluate Coagulation During Cardiopulmonary Bypass with Systemic Heparinization." Anesthesiology. September 1992;77(3A). Mongan P, Hosking M. "The Role of Desmopressin Acetate in Patients Undergoing Coronary Artery Bypass Surgery." Anesthesiology. 1992:77:38-46. Baeuerle JJ, Mongan PD, Hosking MP. "An Assessment of the Duration of Cephapirin-Induced Coagulation Abnormalities as Measured by the [Thrombelastograph® Analyzer]." Anesthesiology. 1991:75(3A). Wong CA, Jones JH, Wade L. "Comparison of Act and TEG[®] in Patients Receiving Autologous Platelet-Rich-Plasma during Cardiac Surgery." Anesthesiology. 1991:75(3A). Lake, CB, ed. "Intraoperative Evaluation of Haemostasis." Clinical Monitoring. Philadelphia: WB Saunders, 1990 pp 558-574. Spiess, BD. "Coagulation Function in Operating Room." The Hemorrhagic Disorders, Anesthesia Clinics of North America. WB Saunders. 1990:13:481-499. Weiss J, McNulty S, Schmitz T. "[Thrombelastograph®] Evaluation of the Effect of Cell Saver Blood on Coagulation in the Post Cardiopulmonary Bypass Patient." Anesthesiology. 1990:72(3A). Spiess BD, Ivankovich AD. "[Thrombelastograph® Analysis]: A Coagulation-Monitoring Technique applied to Cardiopulmonary Bypass." Monograph of the Society of Cardiovascular Anesthesia. Ed. Ellison and Jobes: 1988. Spiess B, Tuman K, McCarthy R, DeLaria A, Schillo R, Ivankovich AD. "[Thrombelastograph® Analysis] as an Indicator of Post-Cardiopulmonary Bypass Coagulopathies." Journal of Clinical Monitoring. 1987:3:25-30. Tuman KJ, Spiess B, McCarthy R, Ivankovich AD. "Effects of Progressive Blood Loss on Coagulation as Measured by [Thrombelastograph® Analysis]." Anesth Analog. 1987:66:856-63. Tuman K, Spiess B, Schoen R, Ivankovich AD. " Use of [Thrombelastograph® Analysis] in the Management of von Willebrand's Disease During Cardiopulmonary Bypass." Journal of Cardiothoracic Anesthesia. 1987:1(4):321-324. |
|
| About Haemoscope
Contact Us |
Benefits | TEG®
System | Test Comparison | Applications
| Publications | Sales | Tech Support | Users | What's New | See You
© Copyright 1998 Haemoscope Corp. Thrombelastograph® and TEG® are registered trademarks of Haemoscope Corp. |